Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
1
20%
Ph not_applicable
1
20%
Ph phase_2
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

completed240%
unknown120%
recruiting240%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_4

Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease

NCT05193552
recruiting

Hizentra® in Inflammatory Neuropathies - pHeNIx Study

NCT04672733
completedphase_2

Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

NCT02100969
completedphase_2

Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig

NCT03730129
unknownnot_applicable

Evaluation of Efficacy and Tolerability of Hizentra®

NCT01354587

Clinical Trials (5)

Showing 5 of 5 trials
NCT05193552Phase 4

Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease

Recruiting
NCT04672733

Hizentra® in Inflammatory Neuropathies - pHeNIx Study

Recruiting
NCT02100969Phase 2

Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

Completed
NCT03730129Phase 2

Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig

Completed
NCT01354587Not Applicable

Evaluation of Efficacy and Tolerability of Hizentra®

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5